11 research outputs found
Nucleic acid cytokine responses in obese children and infants of obese mothers
Almost a third of Irish children are now overweight and the country ranks 58th out of 200 countries for its
proportion of overweight youths. With the rising obesity epidemic, and the impaired immune responses of this
population, it is vital to understand the effects that obesity has on the immune system and to design future
therapeutics, adjuvants and vaccines with overweight and obese populations in mind. Many current vaccines use
adjuvants that have been found to be less effective at stimulating the immune response in children compared
with adults and there is now substantial effort to design paediatric-focused adjuvants. Additionally, vaccine
responses have been shown to be less effective in obese populations indicating that this is a particularly vulnerable population. We have recently identified cytosolic nucleic acids (CNAs), as novel candidate adjuvants for
childhood vaccines. Here we investigated whether immune responses to these candidate adjuvants were adversely affected in infants born to overweight or obese mothers, and in overweight and obese children. Type I
Interferon (IFN) and proinflammatory cytokines such as Tumor Necrosis Factor α (TNFα) are vital for driving
innate and adaptive immune responses. We found that childhood obesity conferred no significant adverse effect
on CNA-induced Type I IFN responses when compared with lean children. Similarly, Type I IFN responses were
intact in the cord blood of babies delivered from overweight and obese mothers, when compared with lean
mothers. There was also no significant impact of obesity on CNA-induced TNFα responses in children or from
cord blood of infants born to overweight/obese mothers. In all cases, there was a tendency towards decreased
production of innate cytokine Type I Interferon and TNFα, however there was no significant negative correlation. Interestingly, high maternal BMI showed weak and moderate positive correlation with IL-12p70 and IFNγ,
respectively, in response to CNA stimulation. This study demonstrates that future adjuvants can be tailored for
these populations through the use of activators of CNA sensors
A single center retrospective comparison of post-tonsillectomy hemorrhage between BiZact and Coblator
INTRODUCTION: Over 550,000 tonsillectomies are performed every year. While post-tonsillectomy hemorrhage (PTH) has been studied in the coblator, bovie, and cold steel technique, there is a dearth of studies examining the post-tonsillectomy outcome using BiZact. This study examines the rate of BiZact PTH requiring control of hemorrhage in the OR and assess resident comfort using the device.
METHODS: Retrospective chart review for all tonsillectomies performed between January 2018 and December 2020 were performed. Rates of PTH were analyzed. In addition, a 7-question BiZact resident experience survey was administered to 25 otolaryngology residents.
RESULTS: 1384 patients were included in this study; 444 (32%) Bizact and 940 (68%) Coblation. 11 (2.48%) BiZact patients had PTH requiring OR for control of hemorrhage, compared to 44 (4.68%) Coblation patients. There were no patient deaths because of PTH. The mean age of patients with PTH was 7.44 (SD 4.07) years old. 22 (88%) residents responded to the survey. 17 (77.27%) felt more confident with Coblator while performing tonsillectomy most commonly reported for ease of use, followed by BiZact 4 (18.18%), most commonly reported for improved surgical plane.
CONCLUSION: BiZact is a safe and effective addition. At our institution, the rate of secondary PTH requiring OR intervention for BiZact is comparable to the national average for other tonsillectomy devices. The rate of BiZact PTH requiring OR intervention in our experience was nearly half of those done with Coblator. Overall residents at SCHC preferred Coblator over BiZact mainly attributed to Coblator\u27s versatility and ability to control intraoperative tonsil bleeding without additional instruments despite BiZact\u27s shorter operative time
Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation
Two million infants die each year from infectious diseases before they reach 12 mo; many of these diseases are vaccine preventable in
older populations. Pattern recognition receptors represent the critical front-line defense against pathogens. Evidence suggests that
the innate immune system does not fully develop until puberty, contributing to impaired response to infection and impaired vaccine
responses in neonates, infants, and children. The activity of the pattern recognition receptor family of cytosolic nucleic acid (CNA)
sensors in this pediatric population has not been reported. We show that in direct contrast to weak TLR-induced type I IFN in
human cord blood mononuclear cells, cord blood mononuclear cells are capable of initiating a potent response to CNA, inducing
both antiviral type I IFN and, unexpectedly, proinflammatory TNF-a. A deficiency in Rab11-GTPase endosome formation and
consequent lack of IRF3 activation in neonatal monocytes is at least in part responsible for the marked disparity in TLR-induced
IFN production between neonatal and adult monocytes. CNA receptors do not rely on endosome formation, and therefore, these
responses remain intact in neonates. Heightened neonatal responses to CNA challenge are maintained in children up to 2 y of age
and, in marked contrast to TLR4/9 agonists, result in IL-12p70 and IFN-g generation. CNA sensors induce robust antiviral and
proinflammatory pathways in neonates and children and possess great potential for use as immunostimulants or vaccine adjuvants
for targeted neonatal and pediatric populations to promote cell-mediated immunity against invasive infectious disease
Effect of Intraoperative High Positive End-Expiratory Pressure (PEEP) With Recruitment Maneuvers vs Low PEEP on Postoperative Pulmonary Complications in Obese Patients: A Randomized Clinical Trial.
IMPORTANCE An intraoperative higher level of positive end-expiratory positive pressure (PEEP) with alveolar recruitment maneuvers improves respiratory function in obese patients undergoing surgery, but the effect on clinical outcomes is uncertain
Effect of intraoperative high Positive End-Expiratory Pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients : a randomized clinical trial
IMPORTANCE An intraoperative higher level of positive end-expiratory positive pressure (PEEP) with alveolar recruitment maneuvers improves respiratory function in obese patients undergoing surgery, but the effect on clinical outcomes is uncertain.
OBJECTIVE To determine whether a higher level of PEEP with alveolar recruitment maneuvers decreases postoperative pulmonary complications in obese patients undergoing surgery compared with a lower level of PEEP.
DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 2013 adults with body mass indices of 35 or greater and substantial risk for postoperative pulmonary complications who were undergoing noncardiac, nonneurological surgery under general anesthesia. The trial was conducted at 77 sites in 23 countries from July 2014-February 2018; final follow-up: May 2018.
INTERVENTIONS Patients were randomized to the high level of PEEP group (n = 989), consisting of a PEEP level of 12 cm H2O with alveolar recruitment maneuvers (a stepwise increase of tidal volume and eventually PEEP) or to the low level of PEEP group (n = 987), consisting of a PEEP level of 4 cm H2O. All patients received volume-controlled ventilation with a tidal volume of 7 mL/kg of predicted body weight.
MAIN OUTCOMES AND MEASURES The primary outcomewas a composite of pulmonary complications within the first 5 postoperative days, including respiratory failure, acute respiratory distress syndrome, bronchospasm, new pulmonary infiltrates, pulmonary infection, aspiration pneumonitis, pleural effusion, atelectasis, cardiopulmonary edema, and pneumothorax. Among the 9 prespecified secondary outcomes, 3 were intraoperative complications, including hypoxemia (oxygen desaturation with SpO(2) 1 minute).
RESULTS Among 2013 adults who were randomized, 1976 (98.2%) completed the trial (mean age, 48.8 years; 1381 [69.9%] women; 1778 [90.1%] underwent abdominal operations). In the intention-to-treat analysis, the primary outcome occurred in 211 of 989 patients (21.3%) in the high level of PEEP group compared with 233 of 987 patients (23.6%) in the low level of PEEP group (difference, -2.3%[95% CI, -5.9% to 1.4%]; risk ratio, 0.93 [95% CI, 0.83 to 1.04]; P =.23). Among the 9 prespecified secondary outcomes, 6 were not significantly different between the high and low level of PEEP groups, and 3 were significantly different, including fewer patients with hypoxemia (5.0% in the high level of PEEP group vs 13.6% in the low level of PEEP group; difference, -8.6%[95% CI, -11.1% to 6.1%]; P <.001).
CONCLUSIONS AND RELEVANCE Among obese patients undergoing surgery under general anesthesia, an intraoperative mechanical ventilation strategy with a higher level of PEEP and alveolar recruitment maneuvers, compared with a strategy with a lower level of PEEP, did not reduce postoperative pulmonary complications